Nourianz
Chemical Name | istradefylline |
Dosage Form | Tablet (oral; 20 mg, 40 mg) |
Drug Class | Receptor antagonists |
System | Musculoskeletal |
Company | Kyowa Kirin Inc. |
Approval Year | 2019 |
Indication
- Nourianz is indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” episodes.